<bill session="117" type="h" number="7790" updated="2023-03-09T17:45:31Z">
  <state datetime="2022-05-18T21:39:23-04:00">PASS_OVER:HOUSE</state>
  <status>
    <unknown datetime="2022-05-18T21:39:23-04:00"/>
  </status>
  <introduced datetime="2022-05-17"/>
  <titles>
    <title type="display">Infant Formula Supplemental Appropriations Act, 2022</title>
    <title type="official" as="introduced">Making emergency supplemental appropriations to address the shortage of infant formula in the United States for the fiscal year ending September 30, 2022, and for other purposes.</title>
    <title type="short" as="introduced">Infant Formula Supplemental Appropriations Act, 2022</title>
    <title type="short" as="passed house">Infant Formula Supplemental Appropriations Act, 2022</title>
  </titles>
  <sponsor bioguide_id="D000216"/>
  <cosponsors/>
  <actions>
    <action datetime="2022-05-17">
      <text>Introduced in House</text>
    </action>
    <action datetime="2022-05-17" state="REFERRED">
      <text>Referred to the Committee on Appropriations, and in addition to the Committee on the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2022-05-17">
      <text>Referred to the Committee on Appropriations, and in addition to the Committee on the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2022-05-17T14:57:07-04:00">
      <text>Rules Committee Resolution H. Res. 1124 Reported to House. Rule provides for consideration of H.R. 350, H.R. 7688 and H.R. 7790. Provides for one of hour of general debate and one motion to recommit for each bill. Resolution also provides for en bloc suspension authority.</text>
    </action>
    <action datetime="2022-05-18T16:47:41-04:00">
      <text>Rule H. Res. 1124 passed House.</text>
    </action>
    <action datetime="2022-05-18T19:33:16-04:00">
      <text>Considered under the provisions of rule H. Res. 1124.</text>
      <reference ref="CR H5158-5163" label="consideration"/>
    </action>
    <action datetime="2022-05-18T19:33:21-04:00">
      <text>Rule provides for consideration of H.R. 350, H.R. 7688 and H.R. 7790. Provides for one of hour of general debate and one motion to recommit for each bill. Resolution also provides for en bloc suspension authority.</text>
    </action>
    <action datetime="2022-05-18T19:35:03-04:00">
      <text>DEBATE - The House proceeded with one hour of debate on H.R. 7790.</text>
    </action>
    <action datetime="2022-05-18T20:15:01-04:00">
      <text>The previous question was ordered pursuant to the rule.</text>
    </action>
    <action datetime="2022-05-18T20:15:42-04:00">
      <text>Mrs. Hinson moved to recommit to the Committee on Appropriations.</text>
      <reference ref="CR H5163" label="text"/>
    </action>
    <action datetime="2022-05-18T20:15:51-04:00">
      <text>The previous question on the motion to recommit was ordered pursuant to clause 2(b) of rule XIX.</text>
    </action>
    <action datetime="2022-05-18T20:16:26-04:00">
      <text>POSTPONED PROCEEDINGS - At the conclusion of debate on the Hinson motion to recommit, the Chair put the question on agreeing to the motion and by voice vote announced that the noes had prevailed. Mrs. Hinson demanded the yeas and nays and the Chair postponed further proceedings until a time to be announced.</text>
    </action>
    <action datetime="2022-05-18T21:17:24-04:00">
      <text>Considered as unfinished business.</text>
      <reference ref="CR H5165-5166" label="consideration"/>
    </action>
    <action datetime="2022-05-18T21:29:37-04:00">
      <text>On motion to recommit Failed by the Yeas and Nays: 202 - 218 (Roll no. 219).</text>
    </action>
    <vote how="roll" type="vote" roll="220" datetime="2022-05-18T21:39:23-04:00" where="h" result="pass" state="PASS_OVER:HOUSE">
      <text>On passage Passed by the Yeas and Nays: 231 - 192 (Roll no. 220).</text>
      <reference ref="CR H5158" label="text"/>
    </vote>
    <action datetime="2022-05-18T21:39:25-04:00">
      <text>Motion to reconsider laid on the table Agreed to without objection.</text>
    </action>
    <action datetime="2022-05-19">
      <text>Received in the Senate. Read the first time. Placed on Senate Legislative Calendar under Read the First Time. (Legislative Day 5/17/2022).</text>
    </action>
    <calendar datetime="2022-05-19" calendar="Senate Legislative" under="General Orders" number="374">
      <text>Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 374.</text>
    </calendar>
  </actions>
  <committees>
    <committee code="HSBU" name="House Budget" subcommittee="" activity="Referral"/>
    <committee code="HSAP" name="House Appropriations" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="117" type="hr" number="1124" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Agriculture and food"/>
    <term name="Appropriations"/>
    <term name="Child health"/>
    <term name="Congressional oversight"/>
    <term name="Department of Health and Human Services"/>
    <term name="Executive agency funding and structure"/>
    <term name="Food and Drug Administration (FDA)"/>
    <term name="Food supply, safety, and labeling"/>
    <term name="Fraud offenses and financial crimes"/>
    <term name="Nutrition and diet"/>
    <term name="Trade restrictions"/>
  </subjects>
  <amendments/>
  <summary date="2022-05-20T18:36:49Z" status="Passed House">Infant Formula Supplemental Appropriations Act, 2022

This bill provides $28 million in emergency supplemental appropriations to address the shortage of infant formula in the United States.

Specifically, the bill provides appropriations for the Food and Drug Administration (FDA) to (1) address the current shortage of FDA-regulated infant formula and certain medical foods in the United States; and (2) prevent future shortages, including by taking the steps that are necessary to prevent fraudulent products from entering the U.S. market.</summary>
</bill>
